SSA
RVPH

Schonfeld Strategic Advisors’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,421
Closed -$17.8K – 2524
2025
Q3 		$17.8K Sell
2,421
-3,942
-62% -$33.5K ﹤0.01% 2110
2025
Q2 		$48.5K Sell
6,363
-6,547
-51% -$102K ﹤0.01% 1888
2025
Q1 		$246K Sell
12,910
-39,995
-76% -$1.26M ﹤0.01% 1870
2024
Q4 		$1.92M Sell
52,905
-22,890
-30% -$637K 0.01% 852
2024
Q3 		$2.18M Buy
75,795
+25,105
+50% +$558K 0.01% 841
2024
Q2 		$1.3M Buy
50,690
+9,360
+23% +$425K 0.01% 1088
2024
Q1 		$3.12M Buy
+41,330
New +$3.28M 0.02% 819

Other funds holding RVPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Schonfeld Strategic Advisors's RVPH Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2025, closing a stake of 2,421 shares — an estimated $17.8K sold.

Schonfeld Strategic Advisors first reported a position in RVPH in Q1 2024 and held it in 7 quarters. The position peaked at $3.12M in Q1 2024. 48 funds tracked by Wall St. Rank hold RVPH as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 2,421 REVIVA PHARMA HLDGS INC shares in Q4 2025, an estimated $17.8K.
  • Schonfeld Strategic Advisors first reported a position in REVIVA PHARMA HLDGS INC in Q1 2024 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's REVIVA PHARMA HLDGS INC position peaked at $3.12M in Q1 2024.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.